• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There is a lack of information about how long-term exposure to these drugs can affect the fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the advantages of using them against the risks to the foetus. Doctors don't have enough data to make unambiguous recommendations but they can provide information on the risks and benefits to help pregnant women make an informed decision.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at higher risk of fetal malformations, or structural birth defects. The researchers used a large population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists looked over the cases to ensure correct case classification and to minimize the chance of bias.

The research conducted by the researchers was not without its limitations. Most important, they were unable to distinguish the effects of the medication from the disorder that is underlying. This limitation makes it difficult for researchers to establish whether the small differences observed between the groups that were exposed to the use of medication, or if they were confounded by comorbidities. Additionally, the researchers did not look at long-term offspring outcomes.

The study did show that infants whose mothers had taken ADHD medications during pregnancy were at a slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had stopped their medications before or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an increased risk of having a caesarean section or having a baby with a low Apgar score (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during early pregnancy could be offset by the greater benefit for both mother and child of continued treatment for the woman's disorder. Physicians should speak with their patients about this issue and as much as possible, assist them develop coping strategies that may reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the dilemma of whether to keep or discontinue treatment during pregnancy is a question that more and more doctors face. These decisions are frequently made without clear and reliable evidence. Instead, doctors have to weigh their own knowledge in conjunction with the experiences of other doctors and the research on the subject.

The issue of possible risks for infants can be difficult to determine. The research on this subject is based on observations rather than controlled studies, and a lot of the results are contradictory. In addition, most studies limit their analysis to live births, which could underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these issues, by examining both information on deceased and live births.

The conclusion is that while certain studies have demonstrated a positive association between ADHD medications and the possibility of certain birth defects, other studies have found no connection and the majority of studies have a neutral or slight negative effect. As a result, a careful risk/benefit assessment must be conducted in every situation.

It can be challenging, if not impossible for women with ADHD to stop taking their medication. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. Furthermore, a loss of medication may affect the ability to complete job-related tasks and drive safely that are crucial aspects of a normal life for many people with ADHD.

She suggests women who are uncertain about whether to keep or stop taking medication for adhd and bipolar (images.google.co.il) because of their pregnancy consider educating family members, friends and colleagues about the condition, its impact on daily functioning, and on the advantages of continuing the current treatment regimen. It can also help a woman feel confident about her decision. It is important to note that certain medications can pass through the placenta so if a woman decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug could be passed on to the baby.

Birth Defects Risk

As the use and misuse of adhd otc medication medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases the concern over the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Researchers used two huge datasets to analyze over 4.3 million pregnancies and determine if stimulant medication use caused birth defects. Researchers discovered that, while the overall risk is low, the first trimester ADHD medication use was associated with slightly higher rates of certain heart defects, like ventriculoseptal defects.

The researchers of the study could not discover any link between early use of medication and other congenital anomalies such as facial deformities or club feet. The results are in line with previous studies that have shown an increase, but not significant, in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the time of pregnancy. This risk increased during the latter half of pregnancy when a large number of women decided to stop taking their medication.

Women who used ADHD medication in the first trimester of their pregnancy were also more likely to experience caesarean sections, a low Apgar score following delivery, and a baby who needed breathing assistance at birth. The researchers of the study were not able to eliminate bias due to selection because they limited their study to women who did not have any other medical conditions that might have contributed to the findings.

Researchers hope that their study will help doctors when they see pregnant women. The researchers advise that, while discussing risks and benefits are important, the decision about whether to continue or stop medication should be made in light of the severity of each woman's ADHD symptoms and her requirements.

The authors warn that, even though stopping the medication is a possibility to look into, it is not recommended due to the high rate depression and other mental problems among women who are pregnant or have recently given birth. Furthermore, research suggests that women who decide to stop their medications are more likely to have a difficult time adjusting to life without them after the birth of their baby.

Nursing

It can be a stressful experience becoming a mother. Women who suffer from best adhd medication for adults who must work through their symptoms while attending physician appointments as well as making preparations for the arrival of a baby and adapting to new routines in the home are often faced with a number of difficulties. Many women choose to continue taking their ADHD medication during pregnancy.

The risk to breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk in low amounts. However, the amount of exposure to medication by the infant can differ based on dosage, how often it is administered and at what time it is administered. In addition, different medications used for adhd are introduced into the baby's system via the gastrointestinal tract or breast milk. The effect on the health of a newborn is not fully understood.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the absence of research. This is a difficult decision for the mother, who must weigh the benefits of continuing her medication against the potential risks to the embryo. Until more information is available, GPs should ask all pregnant patients about their experience with ADHD and whether they are planning or taking to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue taking their ADHD medication safely during pregnancy and while breast-feeding. As a result, many patients are choosing to do so and in consultation with their physician, they have discovered that the benefits of keeping their current medication far outweigh any potential risks.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD recognize their symptoms and the root cause, learn about available treatments and to reinforce existing strategies for managing. This should be a multidisciplinary process with the GPs, obstetricians, and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, as well as monitoring for signs of deterioration, and, if needed modifications to the medication regimen.